Segmental arterial mediolysis: a precursor to fibromuscular dysplasia?

RE Slavin, K Saeki, B Bhagavan… - Modern pathology: an …, 1995 - europepmc.org
We describe five cases of segmental arterial mediolysis (SAM), formerly known as segmental
mediolytic arteritis. SAM occurs in epicardial coronary arteries and in the abdominal …

Structure–activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects

R Takasawa, S Takahashi, K Saeki, S Sunaga… - Bioorganic & medicinal …, 2008 - Elsevier
Glyoxalase I (GLO I) is the rate-limiting enzyme for detoxification of methylglyoxal (MG), a side
product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …

[HTML][HTML] Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: post hoc analysis of six randomized studies

JE Piña-Garza, W Rosenfeld, K Saeki, V Villanueva… - Epilepsy & Behavior, 2020 - Elsevier
Objective This post hoc analysis of six randomized, double-blind, Phase II and III studies
evaluated efficacy and safety of adjunctive perampanel (2–12 mg/day) in adolescent patients (…

Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I

R Takasawa, K Saeki, A Tao, A Yoshimori… - Bioorganic & medicinal …, 2010 - Elsevier
Glyoxalase I (GLO I) is the rate-limiting enzyme for detoxification of methylglyoxal (MG), a
side-product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …

Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study

K Aozasa, K Saeki, M Ohsawa, K Horiuchi, K Mishima… - Cancer, 1993 - Wiley Online Library
Background. Uterine lymphoma is a rare disease; therefore, information regarding histologic
type, immunophenotype of tumor cells, and etiologic factors are limited. Methods. Seven …

Malignant Lymphoma of the Breast: Immunologic Type and Association with Lymphocytic Mastopathy

K Aozasa, M Ohsawa, K Saeki… - American journal of …, 1992 - academic.oup.com
Clinical and pathologic findings in 19 cases of primary non-Hodgkin’s lymphoma of the
breast collected from several hospitals in Japan were reviewed. All patients were women (…

Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore

R Takasawa, A Tao, K Saeki, N Shionozaki… - Bioorganic & medicinal …, 2011 - Elsevier
The human glyoxalase I (hGLO I), which is a rate-limiting enzyme in the pathway for detoxification
of apoptosis-inducible methylglyoxal (MG), has been expected as an attractive target …

Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1

K Saeki, M Machida, Y Kinoshita… - Biological and …, 2011 - jstage.jst.go.jp
MATERIALS AND METHODS Materials The mouse anti-total-tau (TAU-5), and rabbit anti-phospho-tau
(Ser396) antibodies were purchased from Biosource International (Camarillo, CA, …

Structural insights into the hot spot amino acid residues of mushroom tyrosinase for the bindings of thujaplicins

S Takahashi, T Kamiya, K Saeki, T Nezu… - Bioorganic & medicinal …, 2010 - Elsevier
Tyrosinase inhibitors are important agents for cosmetic products. We examined here the
inhibitory effects of three isomers of thujaplicins (α, β and γ) on mushroom tyrosinase and …

[HTML][HTML] Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese …

…, A Ohnishi, S Kaneko, H Hiramatsu, K Saeki… - Seizure, 2018 - Elsevier
Purpose To evaluate long-term tolerability, safety and efficacy of adjunctive perampanel in a
Phase II, multicentre, open-label, dose-ascending Study 231 (NCT00849212) and its …